pSS, primary Sjögren’s syndrome

Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production
Frédéric Lavie, Corinne Miceli-Richard, Marc Ittah, Jérémie Sellam, Jacques-Eric Gottenberg, Xavier Mariette

Annals of the Rheumatic Diseases May 2007, 66 (5) 700-702; DOI: 10.1136/ard.2006.060772
Lymphoma and other malignancies in primary Sjögren’s syndrome: a cohort study on cancer incidence and lymphoma predictors
E Theander, G Henriksson, O Ljungberg, T Mandl, R Manthorpe, L T H Jacobsson

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 796-803; DOI: 10.1136/ard.2005.041186
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren’s syndrome and systemic lupus erythematosus
Jérémie Sellam, Corinne Miceli-Richard, Jacques-Eric Gottenberg, Marc Ittah, Frédéric Lavie, Christine Lacabaratz, Nicolas Gestermann, Alexis Proust, Olivier Lambotte, Xavier Mariette

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 790-797; DOI: 10.1136/ard.2006.065656
Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjögren’s syndrome
A Hartkamp, R Geenen, M Bijl, A A Kruize, G L R Godaert, R H W M Derksen

Annals of the Rheumatic Diseases Oct 2004, 63 (10) 1335-1337; DOI: 10.1136/ard.2003.011825

Main menu